LUMOS DIAGNOSTICS HOLDINGS LIMITED

Press Releases Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E. Other stock markets 11:40:14 09/05/2024 am IST			5-day change	1st Jan Change
0.05 ^AUD	-1.96%		+2.04%	-31.51%

06/05	Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6%	MT
09/04	Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lumos Diagnostics Appoints Doug Ward as CEO	21/22/21	GL
Lumos Diagnostics Appoints Doug Ward as CEO	21/22/21	AQ
Lumos Diagnostics : Letter to Eligible Shareholders	10/22/10	PU
Lumos Diagnostics : Operational Update and Accelerated Entitlement Offer	06/22/06	PU
Lumos Diagnostics : Notification regarding unquoted securities - LDX	01/22/01	PU
Lumos Diagnostics : FY2022 Half Year Update	28/22/28	PU
Lumos Diagnostics : Appendix 4D and Half Year Report	28/22/28	PU
Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies	12/22/12	BU
Lumos Diagnostics Receives Authorization for CoviDx™ SARS-CoV-2 Rapid Antigen Test in Canada	03/21/03	BU
Lumos Diagnostics : Economic Evaluation of Lumos Diagnostics’ FebriDx® Point-of-Care Test Highlights $2.5 Billion in Potential U.S. Healthcare Cost Savings Annually	06/21/06	BU
Lumos Diagnostics : Dr. Jerome Adams, Former U.S. Surgeon General, Joins Lumos Diagnostics as a Strategic Healthcare Adviser	14/21/14	BU
Lumos Diagnostics : FY21 Full Year Results	31/21/31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW